Antineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsCisplatinDoxorubicinChemotherapy, AdjuvantPlatinum CompoundsCombined Modality TherapyCyclophosphamideDisease-Free SurvivalTreatment OutcomeOsteosarcomaPrognosisVincristinePrecursor Cell Lymphoblastic Leukemia-LymphomaOrganoplatinum CompoundsCarboplatinRetrospective StudiesEtoposideNeoadjuvant TherapyBreast NeoplasmsPaclitaxelLung NeoplasmsDrug Administration ScheduleSurvival AnalysisDrug Resistance, NeoplasmNeoplasm StagingNeoplasmsOvarian NeoplasmsSurvival RateMethotrexateAntineoplastic Agents, PhytogenicAntibiotics, AntineoplasticAntimetabolites, AntineoplasticTaxoidsAntineoplastic Agents, AlkylatingVinblastineClinical ProtocolsNeoplasm Recurrence, LocalDeoxycytidineBleomycinIfosfamideInduction ChemotherapyTime FactorsCell Line, TumorDrug Screening Assays, AntitumorCarcinoma, Non-Small-Cell LungCytarabineDose-Response Relationship, DrugAnthracyclinesFollow-Up StudiesSalvage TherapyAdenocarcinomaNeoplasm MetastasisVomitingNauseaNeutropeniaClinical Trials as TopicChemotherapy, Cancer, Regional PerfusionTesticular NeoplasmsCamptothecinLymphoma, Non-HodgkinColorectal NeoplasmsCarmustineApoptosisInfusions, IntravenousProspective StudiesLeukopeniaRadiotherapyTransplantation, AutologousDaunorubicinBrain NeoplasmsMitomycinTumor Cells, CulturedLomustineRadiotherapy, AdjuvantHodgkin DiseaseDacarbazineBone NeoplasmsKaplan-Meier EstimateNeoplasms, Germ Cell and EmbryonalCell SurvivalPeritoneal NeoplasmsDrug SynergismMelphalanCarcinomaTumor Markers, BiologicalNeoplasms, Glandular and EpithelialAntibodies, Monoclonal, HumanizedLiver NeoplasmsInfusions, Intra-ArterialMitoxantroneBridged CompoundsCarcinoma, Squamous CellGranulocyte Colony-Stimulating FactorRecurrenceDrug EvaluationRandomized Controlled Trials as TopicDNA AdductsStomach NeoplasmsAntiemetics